Evaluation of Pharmasolve® corneal permeability enhancement and its irritation on rabbit eyes Evalution of Pharmasolve corneal permeability enhancement Xiang Li et al.

Drug Delivery

Volumn 16, Issue 4, 2009, Pages 224-229

  Li, Xiang ^a   Pan, Weisan ^a   Ju, Chengyi ^b   Liu, Zhidong ^c   Pan, Hao ^a   Zhang, Huihui ^a   Nie, Shufang ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b AustarPharma LLC   (United States)

^c BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Corneal permeability; Ocular irritation; Penetration enhancer; Pharmasolve

Indexed keywords

ENOXACIN; EXCIPIENT; IBUPROFEN; PHARMASOLVE; PUERARIN; RIBAVIRIN; UNCLASSIFIED DRUG; ISOFLAVONE DERIVATIVE; METHYLPYRROLIDINE; N-METHYLPYRROLIDINE; PYRROLIDINE DERIVATIVE; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORNEA PERMEABILITY; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG SCREENING; EXPERIMENTAL RABBIT; EYE IRRITATION; NONHUMAN; PRIORITY JOURNAL; ANIMAL; CORNEA; DRUG EFFECT; EYE; EYE INJURY; HYPODERMOCLYSIS; PATHOPHYSIOLOGY; PERMEABILITY; PHYSIOLOGY; RABBIT;

ANIMALS; CORNEA; ENOXACIN; EYE; EYE INJURIES; HYPODERMOCLYSIS; IBUPROFEN; ISOFLAVONES; PERMEABILITY; PYRROLIDINES; RABBITS; RIBAVIRIN; VASODILATOR AGENTS;

EID: 70350648662     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.1080/10717540902850567     Document Type: Article

References (24)

1. Stjernschantz J, Astin M. (1993). In: Edman P, ed. Biopharmaceutics of Ocular Drug Delivery. Boca Raton, FL: CRC Press, 1.
2. Diane D-S, Tang L, Joseph BR, Robert JW, Harun T. (1994). Effects of four penetration enhancers on corneal permeability of drugs in vitro. J Pharm Sci, 83, 85-90.
3. Fabrizio SM Patrizia C, Riccardo C, Gabriela M, Laura B. (1996). Evaluation of ocular permeation enhancers: in vitro effects on corneal transport of four d£-blockers, and in vitro/in vivo toxic activity. Int J Pharm, 142, 103-113
4. Liu ZD, Li JW, Nie SF, Guo H, Pan WS. (2006). Effects of Transcutol P on the corneal permeability of drugs and evaluation of its ocular irritation of rabbit eyes. J Pharm Pharmacol, 58, 45-50.
5. Sasaki H, Kojima M, Mori Y, Nakamura J, Shibasaki J. (1988). Enhancing effect of pyrrolidone derivatives on transdermal drug delivery I. Int J Pharm, 44, 15-24.
6. Sasaki H, Kojima M, Nakamura J, Shibasaki J. (1990). Acute toxicity and skin irritation of pyrrolidone derivatives as transdermal penetration enhancer. Chem Pharm Bull, 38, 2308-2310 (Pubitemid 20338211)
7. Yoneto K, Ghanem AH, Higuchi WI, Peck KD, Li SK. (1995). Mechanistic studies of the 1-alkyl-2-pyrrolidones as skin permeation enhancers. J Pharm Sci, 84, 312-317
8. Koizumi A, Fujii M, Kondoh M, Watanabe Y. (2004). Effect of N-methyl-2-pyrrolidone on skin permeation of estradiol. Eur J Pharm Biol, 57, 473-478
9. Ren C, Fang L, Li T, Wang M, Zhao L, He Z. 2006. Effect of permeation enhancers and organic acids on the skin permeation of indapamide. Int J Pharm, 142, 103-113
10. Lee PJ, Ahmad N, Langer R, Mitragotri S, Shastri VP. (2006). Evaluation of chemical enhancers in the transdermal delivery of lidocaine. Int J Pharm, 308, 33-39
11. Draize JH, Woodard G, Calvery HO. (1944). Methods for the study of irritation and toxicity of substances. J Pharmacol Exp Ther, 82, 377-390
12. Fitzhugh OG, Woodard G, Braun HA. (1946). The toxicities of compounds related to 2,3-dimercaptopropanol(BAL) with a note on their relative therapeutic efficiency. J Pharm Exp Ther, 87 (suppl), 23-27
13. Schoenwald RD, Huang HS. (1983). Corneal penetration behavior of d£-blocking agents I: Physico chemical factors. J Pharm Sci, 72, 1266-1272
14. Camber O. (1985). An in vitro model for determination of drug permeability through the cornea. Acta Pharm Suec, 78, 815-819
15. Zhang L, Qi G, Zhu H. (2000). Study on pharmacokinetics of transdermal ionphoretic ibuprofen in rabbits. Chin Pharm J, 35, 189-191
16. Liu F. (2001). Determination of ribavirin in ribavirin eye drops. Chin Pharm, 12, 368-369
17. Liu ZD, Pan WS, Nie SF, Li JW, Liu HF. (2004). Investigation on the corneal permeability of enoxacin in vitro. Chin J New Drugs, 13, 1000-1002
18. Song C, Yang X, Liu Z, Zhang Z, Pan W. (2007). Study on release profile of puerarin ophthalmic gel in vitro. Chin J New Drugs, 16, 2045-2056
19. Hansen CM, Just L. 2001. Prediction of environmental stress cracking in plastics with Hansen solubility parameters. Ind Eng Chem Res, 40, 21-25
20. Akhter S, Barry BW. (1985). Absorption through human skin of ibuprofen and flurbiprofen; effect of dose variation, deposited drug film, occlusion and the penetration enhancer N-methyl-2- pyrrolidone. J Pharm Pharmacol, 37, 27-37.
21. Yoneto K, Li SK, Ghanem AH, Crommelin DJ, Higuchi WI. (1995). A mechanistic study of the effects of the 1-alkyl-2-pyrrolidones on bilayer permeability of stratum corneum lipid liposomes: a comparison with hairless mouse skin studies. J Pharm Sci, 84, 853-860
22. Yoneto K, Li SK, Higuchi WI, Shimabayashi S. (1997). Influence of the permeation enhancers 1-alkyl-2-pyrrolidones on permeant partitioning into the stratum corneum. J Pharm Sci, 87, 209-214
23. Seki T, Kawaguchi T, Juni K, Sugibayashi K, Morimoto Y. (1991). Sustained transdermal delivery of zidovudine via controlled release of penetration enhancer. J Contr Rel, 17, 41-48
24. Maurice DM, Riley MV. (1970). Ocular pharmacokinetics. In: Gragmore CN, ed. Biochemistry of the Eye. London: Academic Press, 6-16.